Tumor-associated antigens (TAAs), such as carcinoma embryonic antigen (CEA), alpha-fetoprotein (AFP), and carbohydrate antigen 125 (CA125), are widely used in clinical tumor diagnosis. This evidence concerns the gene AFP and neoplasm.